0.2872
price up icon0.77%   0.0022
pre-market  Pre-market:  .28   -0.0072   -2.51%
loading
Oragenics Inc stock is traded at $0.2872, with a volume of 271.72K. It is up +0.77% in the last 24 hours and down -2.31% over the past month. Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$0.285
Open:
$0.29
24h Volume:
271.72K
Relative Volume:
0.06
Market Cap:
$3.94M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.0336
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
+3.57%
1M Performance:
-2.31%
6M Performance:
-45.73%
1Y Performance:
-80.06%
1-Day Range:
Value
$0.2801
$0.2941
1-Week Range:
Value
$0.2622
$0.31
52-Week Range:
Value
$0.25
$3.43

Oragenics Inc Stock (OGEN) Company Profile

Name
Name
Oragenics Inc
Name
Phone
813-286-7900
Name
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
OGEN's Discussions on Twitter

Compare OGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OGEN
Oragenics Inc
0.2872 3.94M 0 -20.26M -8.25M -8.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Oragenics Inc Stock (OGEN) Latest News

pulisher
Mar 12, 2025

StockNews.com Begins Coverage on Oragenics (NYSE:OGEN) - Defense World

Mar 12, 2025
pulisher
Mar 10, 2025

The Oragenics Inc (OGEN) Stock Is Headed for a Correction - US Post News

Mar 10, 2025
pulisher
Mar 06, 2025

Digital Risk Inc. Launches Digital Footprint Exposure Assessment Tool to Combat Human Cybersecurity Risks - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Australia for Mild Traumatic Brain Injury - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Oragenics, Inc. Submits Investigator’s Brochure for Phase - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain - EIN News

Mar 06, 2025
pulisher
Mar 04, 2025

Oragenics (NYSE:OGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 04, 2025
pulisher
Feb 25, 2025

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Heritage Distilling Co. Cocoa Bomb Chocolate Whiskey Named 'Best Flavored Whiskey” in the United States at Whisky Magazine's World Whiskies Awards - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Oragenics, Inc. to Present Concussion Treatment Advancements at Emergencies in Medicine Conference - Nasdaq

Feb 25, 2025
pulisher
Feb 25, 2025

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, - GlobeNewswire

Feb 25, 2025
pulisher
Feb 24, 2025

Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail

Feb 24, 2025
pulisher
Feb 16, 2025

Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World

Feb 16, 2025
pulisher
Feb 11, 2025

Oragenics, Inc. Announces Partnership with BRAINBox - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Oragenics Partners With BRAINBox To Develop Intranasal Therapy For Concussion Treatment - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Irobot Corp (IRBT) Stock: From Low to High in 52 Weeks - The InvestChronicle

Feb 11, 2025
pulisher
Feb 11, 2025

Adversity is less terrifying than hope: Oragenics Inc (OGEN) - SETE News

Feb 11, 2025
pulisher
Feb 11, 2025

Alkeus Pharmaceuticals Announces Two Presentations of Oral Gildeuretinol Data During the 48th Annual Meeting of the Macula Society Being Held February 12-15, 2025 - The Manila Times

Feb 11, 2025
pulisher
Feb 11, 2025

Oragenics, Inc. Partners with BRAINBox Solutions to Develop Innovative Intranasal Therapy for Concussion Management - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment - Yahoo Finance

Feb 11, 2025
pulisher
Feb 11, 2025

Press Telegram - Financial Content

Feb 11, 2025
pulisher
Feb 10, 2025

Oragenics Inc (AMEX:OGEN): It’s all about numbers this morning - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

Closing Strong: Oragenics Inc (OGEN) Ends at 0.26, Down -9.26 from Last Close - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Market Recap: Lexeo Therapeutics Inc (LXEO)’s Negative Momentum, Closing at 4.95 - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Market Watch: Outset Medical Inc (OM)’s Noteworthy Gain, Closing at 0.81 - The Dwinnex

Feb 10, 2025
pulisher
Feb 07, 2025

Oragenics, Inc. Chief Medical Officer to Speak at Brain Health SummitOn February 5, 2025, Oragenics, Inc. (NYSE American: OGEN) revealed through a press release that its Chief Medical Officer, James P. Kelly, MA, MD, FAAN, FANA, will be a prominent p - Defense World

Feb 07, 2025
pulisher
Feb 07, 2025

Virpax Pharmaceuticals Appoints Charn Deol as Independent DirectorVirpax Pharmaceuticals, Inc. (NASDAQ:VRPX) announced on February 5, 2025, the appointment of Mr. Charn Deol as an independent director of the Company, effective immediately. Mr. D - Defense World

Feb 07, 2025
pulisher
Feb 06, 2025

There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Views of Wall Street’s Leading Experts on Oragenics Inc - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Power Nickel's (TSX.V: PNPN) Hole Delivers "BIG"- Gold Terra - openPR

Feb 05, 2025
pulisher
Feb 05, 2025

Power Nickel’s (TSX.V: PNPN) Hole Delivers “BIG”- Gold Terra (TSX.V: YGT) Developments and Exploration Progress Reported – More Stocks Inside! | FinancialContent Business Page - Financial Content

Feb 05, 2025
pulisher
Feb 05, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 05, 2025
pulisher
Feb 05, 2025

OGEN’s valuation metrics: A comprehensive analysis - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Unum Group to Present at the 2025 UBS Financial Services Conference - Yahoo Finance UK

Feb 05, 2025
pulisher
Feb 05, 2025

In the Green: Oragenics Inc (OGEN) Closes at 0.28, Up/Down -2.34 from Previous Day - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Closing Bell Recap: Merck & Co Inc (MRK) Ends at 90.74, Reflecting a -9.07 Downturn - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Market Insights: 4D Molecular Therapeutics Inc (FDMT)’s Notable Drop of -0.17, Closing at 5.92 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Post-Trade Analysis: Charter Communications Inc (CHTR) Slides -0.36, Closing at 340.26 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

US Stocks Mixed; Walt Disney Posts Upbeat Earnings - Benzinga

Feb 05, 2025
pulisher
Feb 05, 2025

United Micro Electronics ADR [UMC] Investment Guide: What You Need to Know - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Oragenics Inc (OGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

The Potential Rise in the Price of Dolby Laboratories Inc (DLB) following insiders activity - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Oragenics Inc Inc. (OGEN) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

PCSO Lotto Results | February 5, 2025 - The Manila Times

Feb 05, 2025
pulisher
Feb 05, 2025

Oragenics, Inc. CMO James P. Kelly to Speak at 12th Annual Brain Health Summit During Super Bowl Weekend - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 - yourbigsky.com

Feb 05, 2025
pulisher
Feb 05, 2025

Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News

Feb 05, 2025
pulisher
Jan 31, 2025

Nisa Investment Advisors LLC Sells 121,826 Shares of Hudson Pacific Properties, Inc. (NYSE:HPP) - Defense World

Jan 31, 2025

Oragenics Inc Stock (OGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):